Breast Imaging Market Overview:
The Breast Imaging Market is expected to expand at a compound annual growth rate (CAGR) of 7-9% over the forecast period. Key drivers of this growth include the rising incidence of breast cancer, a growing emphasis on contrast-based diagnostic methods, a supportive environment for funding and grants, increased awareness around early breast cancer detection, and ongoing advancements in breast imaging technologies.
Download Sample PDF: https://meditechinsights.com/breast-imaging-market/request-sample/
Competitive Landscape
Key players in the global breast imaging market include:
Hologic, Philips, Siemens Healthineers, GE HealthCare, Koning Health, Canon Medical Systems, Fujifilm, and SonoCiné, among others.
Breast Imaging: Overview and Market Dynamics
Breast imaging is a specialized branch of diagnostic radiology focused on capturing detailed images of the breasts for screening or diagnostic purposes.
Types of Breast Imaging Techniques
- Mammography:
Mammography uses X-rays to detect abnormalities in breast tissue for both screening and diagnostic applications. Skilled technologists ensure optimal positioning, compression, and technique to minimize radiation exposure. Modern mammograms often incorporate digital breast tomosynthesis (3D mammography), which enhances early cancer detection and reduces false-positive results. - Ultrasound:
Breast ultrasound employs high-frequency sound waves to generate images of breast tissue, revealing structure, composition, and blood flow in suspicious areas. Performed by specialized sonographers, this painless, non-invasive technique is commonly used as a follow-up to evaluate findings from mammograms or physical exams. - Magnetic Resonance Imaging (MRI):
For patients diagnosed with or at high risk of breast cancer, breast MRI provides highly detailed, radiation-free, 3D images. Advanced 3T scanners are used for screening, staging, treatment evaluation, and pre-surgical planning. Comfort-enhancing measures, such as eye covers and warm blankets, are typically provided during the 45-minute procedure. - Image-Guided Breast Biopsy:
A minimally invasive biopsy uses advanced imaging to guide precise needle placement for tissue sampling. The extracted tissue is examined microscopically to confirm or rule out the presence of cancer cells.
Technological Advancements Fuel Market Growth
The global breast imaging market continues to expand, driven by rapid technological innovations and product introductions.
- GE HealthCare (November 2023): Launched the MyBreastAI Suite, an integrated AI platform designed to assist clinicians in breast cancer detection and workflow optimization. It incorporates AI applications from iCAD for breast density assessment and reporting.
- Siemens Healthineers (September 2023): Introduced Mammomat B.brilliant, a new mammography system featuring wide-angle tomosynthesis that delivers high-resolution 3D images in just five seconds.
- iSono Health (May 2022): Received FDA clearance for the ATUSA™ System, the first compact automated whole-breast ultrasound device. It includes a wearable accessory and intuitive software for automated image capture and analysis.
Download Sample PDF: https://meditechinsights.com/breast-imaging-market/request-sample/
Awareness Initiatives Driving Market Demand
Breast cancer remains one of the leading causes of cancer-related deaths among women, particularly in low- and middle-income countries. Global initiatives and awareness campaigns continue to play a vital role in increasing screening rates and driving demand for breast imaging technologies.
- World Health Organization (2021): Launched the Global Breast Cancer Initiative (GBCI) with the goal of reducing global breast cancer mortality by 2.5% per year—potentially preventing 2.5 million deaths by 2040. Key objectives include diagnosing 60% of invasive cases at an early stage (Stage I or II), ensuring complete evaluation within 60 days of suspicion, and providing comprehensive treatment to at least 80% of diagnosed women.
- Breast Cancer Awareness Month (October): An annual global campaign to promote breast cancer awareness, early detection, and preventive screening.
Rising Prevalence of Breast Cancer Boosts Market Growth
The global incidence of breast cancer is rising in both developed and developing nations, creating an increasing demand for advanced diagnostic imaging tools. Governments and healthcare organizations are emphasizing early detection to improve survival outcomes.
According to research from the International Agency for Research on Cancer (IARC), by 2040, breast cancer cases are projected to exceed 3 million new diagnoses annually (a 40% increase) and over 1 million deaths per year (a 50% rise). Currently, breast cancer accounts for 1 in 8 cancer diagnoses worldwide, making it the most common form of cancer. This rising disease burden is expected to significantly propel the global breast imaging market.
Growth Strategies and Future Outlook
Market participants are pursuing both organic and inorganic growth strategies—including product launches, acquisitions, and strategic partnerships—to strengthen their market position.
- QT Imaging & GigCapital5 (December 2022): Announced a business combination to bring advanced breast and full-body imaging solutions to public markets. In September 2022, QT Imaging received FDA 510(k) clearance for its QT Imaging Breast Scanner.
- iCAD, Inc. & Google Health (November 2022): Entered a strategic collaboration to integrate Google’s AI technology into iCAD’s suite of breast imaging AI solutions.
Browse Report: https://meditechinsights.com/breast-imaging-market/
About Medi-Tech Insights;
Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.
Contact:
Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
